In Q4 2025, DuPont generated $1.69B in net sales, with operating EBITDA improving year over year due to favorable mix and cost productivity. The company posted a GAAP loss from continuing operations, while adjusted EPS increased, and transaction-adjusted free cash flow strengthened.

DuPont delivered strong Q3 2025 performance with $3.07B in revenue and $840M in operating EBITDA, supported by demand in electronics, healthcare, and water markets. The company announced a $2B share buyback plan and raised FY2025 EBITDA guidance.

DuPont delivered a strong second quarter in 2025, with net sales increasing by 3% and organic sales growing by 2% year-over-year. The company saw solid margin expansion in both ElectronicsCo and IndustrialsCo segments, leading to a 15% increase in adjusted EPS. This performance was driven by continued strength in electronics, healthcare, and water end-markets, along with effective operational execution. As a result, DuPont has raised its full-year 2025 earnings guidance.

DuPont delivered higher revenue and adjusted EPS in Q1 2025, supported by strong demand in electronics, healthcare, and water segments. However, a $768 million goodwill impairment related to segment realignment led to a net loss.

DuPont reported strong Q4 2024 results with net sales of $3.092 billion, a 7% year-over-year increase. Adjusted EPS rose 30% to $1.13, while operating EBITDA grew 13% to $807 million. The company's Water & Protection and Electronics & Industrial segments drove sales growth, supported by higher demand in semiconductor technologies and medical packaging. Cash provided by operations was $564 million, with transaction-adjusted free cash flow of $455 million.

DuPont reported a 4% increase in net sales to $3.2 billion, with organic sales up 3%. GAAP EPS from continuing operations was $1.13, and adjusted EPS was $1.18. The company raised its full-year 2024 operating EBITDA and adjusted EPS guidance.

DuPont reported Q2 2024 net sales of $3.2 billion, a 2% increase year-over-year. The company's adjusted EPS was $0.97, up 14% from the previous year. DuPont is raising its full year 2024 guidance for net sales, operating EBITDA and adjusted EPS.

DuPont reported a decrease in net sales by 3% to $2.9 billion, with a 6% organic sales decline. However, the company's financial results exceeded expectations due to better-than-expected volumes and a focus on operational execution and cost discipline. The electronics market showed continued recovery, particularly in Semiconductor Technologies and Interconnect Solutions. DuPont raised its full-year 2024 guidance for net sales, operating EBITDA, and adjusted EPS.

DuPont reported Q4 2023 net sales of $2.9 billion, a 7% decrease year-over-year, with a GAAP loss from continuing operations of $(300) million. Adjusted EPS was $0.87. The company completed a $2 billion accelerated share repurchase and announced a new $1 billion share repurchase program.

DuPont reported a decrease in net sales by 8% to $3.1 billion, with organic sales declining by 10%. Despite volume headwinds, the company demonstrated operating execution with a 5% sequential operating EBITDA growth and margin improvement. Strong cash generation was highlighted, and the sale of the Delrin® business was completed.

DuPont reported Q2 2023 results with net sales of $3.1 billion, a 7% decrease from the previous year. However, the company's revenue and operating EBITDA exceeded expectations with sequential revenue and earnings growth and margin improvement. Strength was seen in industrial end-markets, while consumer-driven businesses within electronics experienced softness.

DuPont reported net sales of $3.0 billion, an 8% decrease from the previous year, with organic sales down by 3%. GAAP income from continuing operations was $273 million, with an operating EBITDA of $714 million. The company's GAAP EPS from continuing operations was $0.58, and adjusted EPS was $0.84. Operating cash flow was $343 million, and adjusted free cash flow was $102 million.

DuPont reported a 4% decrease in net sales to $3.1 billion for Q4 2022, but organic sales increased by 5%. GAAP income from continuing operations was $105 million, with an operating EBITDA of $758 million. GAAP EPS from continuing operations was $0.20, while adjusted EPS was $0.89.

DuPont reported a 4% increase in net sales to $3.3 billion for Q3 2022, with organic sales growing by 11%. The company's GAAP EPS from continuing operations was $0.69, and adjusted EPS was $0.82, a 4% increase year-over-year. DuPont also announced a new $5.0 billion share repurchase program and the intent to retire $2.5 billion of Senior Notes due in November 2023.

DuPont reported Q2 2022 financial results ahead of expectations, with net sales of $3.3 billion, a 7% increase from the previous year, and organic sales growth of 9%. The company's adjusted EPS increased by 11% to $0.88, and operating EBITDA increased by 6% to $829 million.

DuPont reported a 9% increase in net sales to $3.3 billion and a GAAP EPS of $0.42. The company's operating EBITDA increased by 2% to $818 million, driven by pricing actions and volume gains that offset higher inflationary costs. DuPont's performance reflects its agility in navigating global supply chain challenges and cost inflation.

DuPont reported a 14% increase in net sales to $4.3 billion and a 13% increase in organic sales versus the year-ago period. GAAP EPS from continuing operations was $0.47, while adjusted EPS was $1.08. The company issued 2022 guidance with adjusted EPS expected to be in the range of $4.60 to $4.90 per share.

DuPont reported strong Q3 2021 results, exceeding expectations with an 18% increase in net sales to $4.3 billion and a 20% rise in operating EBITDA to $1.09 billion. The company is advancing its position as a premier multi-industrial company by acquiring Rogers Corporation and exploring options to divest a substantial portion of the Mobility & Materials segment.

DuPont reported strong second-quarter results with net sales of $4.1 billion, up 26% year-over-year, and organic sales up 23%. GAAP EPS was $1.04, and adjusted EPS was $1.06. The company raised its full-year guidance for net sales, operating EBITDA, and adjusted EPS.

DuPont reported strong first-quarter results, exceeding expectations with organic sales growth across all segments. The company benefited from leading positions in key end-markets and advanced its strategic priorities through business separations, acquisitions, and share repurchases.

DuPont reported Q4 2020 results with net sales of $5.3 billion, a 1% increase year-over-year. GAAP EPS from continuing operations was $0.37, and adjusted EPS was $0.95. The company highlighted strong performance in Electronics & Imaging and progress in cost savings, while also focusing on strategic priorities such as the separation of the Nutrition & Biosciences business.

DuPont reported a decrease in net sales and earnings per share (EPS) for the third quarter of 2020 compared to the previous year. Net sales totaled $5.1 billion, down 6 percent, and GAAP EPS from continuing operations was $(0.11). However, the company achieved $1.3 billion in operating cash flow and $1.1 billion in free cash flow.

DuPont reported Q2 2020 results, delivering ahead of expectations despite the ongoing pandemic. Net sales totaled $4.8 billion, down 12 percent, with organic sales down 10 percent. Adjusted EPS was $0.70. The company saw strength in Tyvek® protective garment and water end markets, achieving double digit revenue growth for the second consecutive quarter.

DuPont reported a decrease in net sales and GAAP EPS, but managed to exceed initial expectations in its core segments. The company is focused on managing working capital and aligning production with demand, while also strengthening its balance sheet.

DuPont's Q4 2019 net sales were $5.2 billion, a 5% decrease compared to the same quarter last year, with organic sales down 2%. Adjusted EPS decreased by 34% to $0.95, driven by lower segment results and a higher tax rate. The company is planning a merger of its Nutrition & Biosciences business with IFF.